Filters: Keyword is Adjuvants, Immunologic [Clear All Filters]
2009
2004
Dolan BP, Phelan TP, Ilkovitch D, Qi L, Wade WF, Laufer TM, Ostrand-Rosenberg S.
2004. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.. Journal of immunology (Baltimore, Md. : 1950). 172(2):907-14. Abstract
2003
1999
Soergel SA, MacEwen EG, Vail DM, Potter DM, Sondel PM, Helfand SC.
1999. The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma.. Journal of immunotherapy (Hagerstown, Md. : 1997). 22(5):443-53. Abstract
1995
Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.
1995. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10):1165-70. Abstract







